OTC : CMRA

Comera Life Sciences Holdings, Inc. — Earnings Estimates

$0.0001 USD

$0 (0.0%)

Volume
730
Average Volume
948
Market Capitalization
$3.07K
P/E Ratio
0.00
Dividend Yield
0.00%
Price Target
Year High
$0.00
Year Low
$0.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.61

Annual earnings financials

CMRA financial data with annual/quarterly toggle

CMRA GAAP EPS - Annual & Quarterly

CMRA Sales Revenue - Annual & Quarterly

CMRA Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

CMRA Estimated and Actual Revenue by Quarter
CMRA Estimated and Actual EPS by Quarter
CMRA Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2024-09-30 1 -184.13K -184.13K -184.13K -184.13K -184.13K -184.13K
2024-06-30 1 -170.79K -170.79K -170.79K -170.79K -170.79K -170.79K
2024-03-30 1 -158.42K -158.42K -158.42K -158.42K -158.42K -158.42K
2023-12-30 1 -146.95K -146.95K -146.95K -146.95K -146.95K -146.95K
2023-09-29 1 -136.31K -136.31K -136.31K -136.31K -136.31K -136.31K
CMRA Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2024-09-30 1 35.63M 35.63M 35.63M 1.96M 1.96M 1.96M
2024-06-30 1 31.03M 31.03M 31.03M 1.81M 1.81M 1.81M
2024-03-30 1 36.44M 36.44M 36.44M 1.68M 1.68M 1.68M
2023-12-30 1 48.27M 48.27M 48.27M 1.56M 1.56M 1.56M
2023-09-29 1 32.08M 32.08M 32.08M 1.45M 1.45M 1.45M
CMRA Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2024-09-30 1 184.13K 184.13K 184.13K 1 1.54141 1.54141 1.54141
2024-06-30 1 170.79K 170.79K 170.79K 1 1.34259 1.34259 1.34259
2024-03-30 1 158.42K 158.42K 158.42K 1 1.57645 1.57645 1.57645
2023-12-30 1 146.95K 146.95K 146.95K 1 2.08841 2.08841 2.08841
2023-09-29 1 136.31K 136.31K 136.31K 1 1.38812 1.38812 1.38812